Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cescon, David W."'
Autor:
Wilson BE; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, 700U, 7-305W, Toronto, ON, M5G 2M9, Canada.; University of New South Wales, Kensington, NSW, Australia., Gorrini C; Princess Margaret Cancer Centre, University Health Network, Toronto, China. chiara.gorrini@icr.ac.uk.; Paediatric Solid Tumour Biology and Therapeutics, The Institute of Cancer Research, London, UK. chiara.gorrini@icr.ac.uk., Cescon DW; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, 700U, 7-305W, Toronto, ON, M5G 2M9, Canada. dave.cescon@uhn.ca.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jan; Vol. 191 (2), pp. 257-267. Date of Electronic Publication: 2021 Nov 03.
Autor:
Hernando-Calvo A; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network, University of Toronto, Toronto, Canada. alberto.hernandocalvo@uhn.ca., Cescon DW; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network, University of Toronto, Toronto, Canada., Bedard PL; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network, University of Toronto, Toronto, Canada.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jan; Vol. 191 (1), pp. 15-29. Date of Electronic Publication: 2021 Oct 08.
Autor:
Goldvaser H; Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada.; Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, 6997801, Tel Aviv, Israel., Majeed H; Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada., Ribnikar D; Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada., Šeruga B; Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, 1000, Ljubljana, Slovenia., Ocaña A; Translational Research Unit, Albacete University Hospital and CIBERONC, calle Francisco Javier de Moya, 02006, Albacete, Spain., Cescon DW; Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada., Amir E; Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada. eitan.amir@uhn.ca.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Jun; Vol. 169 (3), pp. 413-425. Date of Electronic Publication: 2018 Feb 08.
Autor:
Pezo RC; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada.; Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada., Chen TW; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Berman HK; Laboratory Medicine Program, University Health Network, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Mulligan AM; Laboratory Medicine Program, University Health Network, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Razak AA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada.; Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada., Cescon DW; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Amir E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Elser C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Warr DG; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Sridhar SS; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Yu C; Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada., Wang L; Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada., Stockley TL; Laboratory Medicine Program, University Health Network, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada., Kamel-Reid S; Laboratory Medicine Program, University Health Network, Toronto, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Canada., Bedard PL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 7-723 700 University Avenue, Toronto, Canada. philippe.bedard@uhn.ca.; Department of Medicine, University of Toronto, Toronto, Canada. philippe.bedard@uhn.ca.; Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, Canada. philippe.bedard@uhn.ca.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Feb; Vol. 168 (1), pp. 159-168. Date of Electronic Publication: 2017 Nov 24.
Autor:
Cescon DW; Mount Sinai Hospital, 1284-600 University Avenue, Toronto, ON, M5G 1X5, Canada., Ganz PA, Beddows S, Ennis M, Mills BK, Goodwin PJ
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Jul; Vol. 134 (2), pp. 759-67. Date of Electronic Publication: 2012 Jun 16.